Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin

McClain

Albers

Buller

Harrington

Hylek

Wittkowsky

Higashi

Sanderson

Wadelius

Rost

Loebstein

Reynolds

Linder

King

Gudgeon

Haddow, 2003, ACCE: a model process for evaluating data on emerging genetic tests

Rieder

Palomaki

Palomaki

American College of Medical Genetics Standards and Guidelines for Clin Genet Laboratories, 2006. Available at: http://www.acmg.net/Pages/ACMG_Activities/stds-2002/stdsmenu-n.htm. Accessed October 1, 2007.

Clinical Laboratory Standards Institute (CLSI). Molecular diagnostic methods for genetic disease; approved guidelines CLSI document MM01–A2. Wayne, PA: Clinical and Laboratory Institute, 2006.

Organization for Economic Co-Operation and Development. Guidelines for quality assurance in molecular genetic testing, 2007. Available at: http://www.oecd.org/document/24/0,3343,en_2649_34537_1885208_1_1_1_1,00.html Accessed October 1, 2007.

National Academy of Clinical Biochemistry. Draft guidelines and recommendations for laboratory analysis and application of pharmacogenetics to clinical practice, 2006. Available at: http://aacc.org/AACC/members/nacb/LMPG/OnlineGuide/DraftGuidelines/Pharmacogenetics/ Accessed October 1, 2007.

Aithal

Millican

Lee

Imai

Tai

Lee

Lindh

Peyvandi

Reitsma

ACMGrecommendations for standards for interpretation of sequence variations, 2006. Available at: http://www.acmg.net/resources/policies/pol-027.pdf Accessed October 1, 2007.

Hillman

Wadelius

Shikata

Gage

McBane

Warfarin dosing, 2006. Available at: http://WarfarinDosing.org Accessed October 1, 2007.

Limdi

Next generation pharmaceuticals, 2007. Available at: http://www.‘ngpharma.com/pastissue/article.asp?art=269086&issue=185’.2007 Accessed October 1, 2007.